The price Eli Lilly is paying for protein drug developer and portfolio company Protomer could potentially top $1bn dependent on milestone payments.

Ionis Pharmaceuticals' stake in the muscular disease treatment developer will be cut in an offering set to raise between $95m and $107m.

Electric aircraft developer Heart Aerospace raised $35m from investors including Mesa Air and United, while several corporates are set to exit remote access software developer Openpath.

MIT’s battery technology spinout will collect $200m in a private investment in public equity financing and list on the New York Stock Exchange.

The Ant Group, Info Edge and Delivery Hero-backed restaurant listings and food delivery app operator is floating in a dual listing, having secured $562m from anchor investors yesterday.

General Motors, Hyundai, Kia, Geely, SAIC Motor, Koch Industries, Foxconn and LG took part in a $200m PIPE supporting a $3.6bn reverse merger for lithium-metal battery developer SES.

The corporate-backed bulk grocery retailer has ceased operations approximately a year after it was formed by a merger between Tongcheng Life and Linlinyi.

Th heart disease treatment developer has secured $248m in funding since being formed to exploit UT Southwestern and Gladstone Institute research.

The digital wallet developer’s $255m IPO would allow Cisco, GMO, American Express, Bajaj Finance, MediaTek, Net1 and New Delhi Television to exit.

Alphabet, GeneScience, AstraZeneca, Shire, Novartis, Ping An, KPC and Stevanato are in line for exits after the drug delivery technology developer filed to go public.